LabGenius

Series-B+
labgeniustx.com Biotech & Healthcare London, United Kingdom Founded 2012 51-100
Total Funding $73M
Latest Round $44M Series-B+
Last Announced May 21, 2024
Investors 25 Backers
Decision Makers 6 Verified

About LabGenius

LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the discovery of next-generation therapeutic antibodies for solid tumours.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters London, United Kingdom
Year Founded 2012
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website labgeniustx.com
Domain Registered Date Dec 3, 2024

Social & Network Presence

X / Twitter Profile @labgeni_us (2.6K followers) Created on Oct 2012
LinkedIn Corporate Not linked

Company Milestones & Timeline

7 Events
  1. Milestone

    Website domain registered

    labgeniustx.com

  2. Capital Raise

    Raised $44,000,000 · Series-B+

    startupintros.com

  3. Capital Raise

    Raised $15,000,000 · Series-A

    startupintros.com

  4. Capital Raise

    Raised $10,000,000 · Series-A

  5. Capital Raise

    Raised $4,000,000 · Seed

    startupintros.com

  6. Milestone

    X account created (@labgeni_us)

    2.6K followers

  7. Milestone

    Company founded

    London, United Kingdom

Investors & Backers

25
Acequia Capital (AceCap)
Air Street Capital
Atomico
BACKED VC
Beast Ventures
Berggruen Holdings
Champion Hill Labs
Charlie Songhurst
Christopher Gibson
Felicis
Gigafund
Innovate UK
Inovia Capital
Kindred Capital
LG Innovation Ventures
Lux Capital
M Ventures
Obvious Ventures
Octopus Ventures
Patrick Pichette
Recode Health Ventures
System.One
TGM ventures
Thomas McInerney
Tiny Supercomputer Investment Company

Funding History

4 Rounds
Series-B+ · May 21, 2024
Series-A · Oct 1, 2020
Series-A · Oct 22, 2019
$10,000,000 Source
Seed · Nov 1, 2017

Founders & Leadership

5

Angus Sinclair

Chief Scientific Officer

Work email & phone locked Unlock →

Dr. Didier Landais

Chief Operating Officer

Work email & phone locked Unlock →

Harry Rickerby

Founder

Work email & phone locked Unlock →

James Field

Founder

Work email & phone locked Unlock →

Staffan Piledahl

Software Engineer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts